HINGHAM, Mass., May 15, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today reported financial and operational results for the quarter ended March 31, 2017, as well as recent corporate progress.
“During the first quarter, we made significant progress advancing our TipCAT and ViRob technology platforms, including several achievements that will act as powerful catalysts in the second half of the year,” commented Harel Gadot, CEO, President and Chairman. “We have partnered with leading academic institutions to validate our technology and strengthened our management team and Board of Directors to ensure we have the additional experience and expertise to continue executing our short and long term goals.”
